View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
February 17, 2010

New Selfcheck Device Available for Diabetes Patients

The A1CNow Selfcheck, which can be used by diabetes patients to check their A1C level at home in between doctor visits, has been developed in the US. A1CNow Selfcheck enables patients to more closely look at their A1C level between doctor visits and allow them to have a more informed di

By cms admin

The A1CNow Selfcheck, which can be used by diabetes patients to check their A1C level at home in between doctor visits, has been developed in the US.

A1CNow Selfcheck enables patients to more closely look at their A1C level between doctor visits and allow them to have a more informed discussion with their doctor to ensure their diabetes plan is working.

The system, cleared by the Food and Drug Administration in 2009, complements the healthcare provider-administered A1C test but is not intended to replace it or routine blood glucose testing.

The system manufactured by Bayer Diabetes Care comes as a two-test-kit, which costs $29.99.

Measuring A1C levels is important for long-term diabetes management, as even a 1% point reduction in A1C may lower the risk of complications by up to 40%.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management